Total Payments
$1,747
2024 Payments
$474.57
Companies
23
Transactions
56
Medicare Patients
2,256
Medicare Billing
$511,996
Payment Breakdown by Category
Food & Beverage$1,727 (98.8%)
Education$20.40 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,727 | 55 | 98.8% |
| Education | $20.40 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $331.76 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $260.64 | 10 | $0 (2024) |
| ABBVIE INC. | $231.66 | 3 | $0 (2024) |
| Incyte Corporation | $139.98 | 2 | $0 (2023) |
| Tempus AI, Inc | $121.52 | 2 | $0 (2024) |
| PFIZER INC. | $120.35 | 7 | $0 (2024) |
| Adaptive Biotechnologies Corporation | $77.51 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $73.03 | 3 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $73.00 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $53.22 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $474.57 | 17 | Tempus AI, Inc ($121.52) |
| 2023 | $213.04 | 12 | Regeneron Healthcare Solutions, Inc. ($47.00) |
| 2022 | $451.20 | 12 | Incyte Corporation ($125.00) |
| 2021 | $48.67 | 3 | Janssen Biotech, Inc. ($25.11) |
| 2020 | $110.40 | 1 | Novartis Pharmaceuticals Corporation ($110.40) |
| 2019 | $101.65 | 4 | E.R. Squibb & Sons, L.L.C. ($70.02) |
| 2018 | $34.98 | 3 | Helsinn Therapeutics (U.S.), Inc. ($12.59) |
| 2017 | $312.48 | 4 | E.R. Squibb & Sons, L.L.C. ($219.08) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $98.51 | General |
| 08/15/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Oncology | ||||||
| 06/20/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 05/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.30 | General |
| 04/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $108.64 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: ONCOLOGY | ||||||
| 04/14/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 03/27/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.01 | General |
| 02/12/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2024 | Immunocore Limited | KIMMTRAK (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Oncology | ||||||
| 01/10/2024 | PFIZER INC. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 01/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Oncology | ||||||
| 12/14/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 12/02/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Oncology | ||||||
| 11/21/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Oncology | ||||||
| 11/02/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 549 | 1,303 | $279,355 | $132,216 |
| 2022 | 7 | 633 | 1,303 | $286,549 | $142,331 |
| 2021 | 6 | 564 | 1,219 | $230,852 | $129,730 |
| 2020 | 8 | 510 | 1,203 | $218,942 | $107,719 |
Total Patients
2,256
Total Services
5,028
Medicare Billing
$511,996
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 345 | 920 | $175,720 | $81,122 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 97 | 269 | $72,899 | $36,407 | 49.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $12,321 | $6,079 | 49.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 35 | $10,815 | $5,042 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,064 | $1,981 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 26 | $3,536 | $1,585 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 345 | 751 | $140,966 | $66,480 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 130 | 386 | $102,915 | $53,752 | 52.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 61 | 61 | $19,935 | $10,327 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $8,890 | $4,070 | 45.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $6,798 | $3,914 | 57.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 24 | $3,844 | $2,224 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $3,201 | $1,564 | 48.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 291 | 821 | $137,385 | $74,966 | 54.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 95 | 215 | $49,375 | $30,431 | 61.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 52 | 52 | $16,380 | $9,155 | 55.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $13,462 | $6,883 | 51.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 28 | 28 | $8,652 | $5,240 | 60.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 50 | $5,598 | $3,056 | 54.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 249 | 815 | $134,475 | $64,829 | 48.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 65 | 180 | $39,780 | $20,556 | 51.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 51 | 51 | $12,954 | $6,418 | 49.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 31 | 31 | $9,765 | $5,136 | 52.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 31 | 31 | $9,579 | $4,933 | 51.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 59 | $6,549 | $2,790 | 42.6% |
About Dr. Hammad Shafqat, MD
Dr. Hammad Shafqat, MD is a Hematology & Oncology healthcare provider based in Mount Vernon, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1093070302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hammad Shafqat, MD has received a total of $1,747 in payments from pharmaceutical and medical device companies, with $474.57 received in 2024. These payments were reported across 56 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,727).
As a Medicare-enrolled provider, Shafqat has provided services to 2,256 Medicare beneficiaries, totaling 5,028 services with total Medicare billing of $511,996. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Mount Vernon, IL
- Active Since 07/12/2012
- Last Updated 03/24/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1093070302
Products in Payments
- VENCLEXTA (Drug) $231.66
- OPDIVO (Biological) $185.84
- KISQALI (Drug) $159.34
- MONJUVI (Drug) $125.00
- clonoSEQ (Device) $77.51
- LIBTAYO (Biological) $73.03
- Somatuline Depot 120mg-.5ml (Drug) $73.00
- TUKYSA (Drug) $59.86
- PROMACTA (Drug) $58.96
- IBRANCE (Drug) $48.00
- Lenvima (Drug) $36.98
- XTANDI (Drug) $36.35
- LYNPARZA (Drug) $32.01
- ADAKVEO (Biological) $23.56
- OPDUALAG (Drug) $20.92
- BESPONSA (Biological) $20.40
- KIMMTRAK (Drug) $20.03
- PLUVICTO (Drug) $18.78
- Nplate (Biological) $17.65
- SARCLISA (Biological) $15.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mount Vernon
Jaideep Shenoi, Md, MD
Hematology & Oncology — Payments: $75,285
Hematology & Oncology $75,285
Kiarash Kojouri, M.d, M.D
Hematology & Oncology — Payments: $17,504
Hematology & Oncology $17,504
Dr. Junfeng Wang, M.d, M.D
Hematology & Oncology — Payments: $10,593
Hematology & Oncology $10,593
Dr. Yagnesh Oza, M.d, M.D
Hematology & Oncology — Payments: $901.88
Hematology & Oncology $901.88
Bruce Mathey, Md, MD
Hematology & Oncology — Payments: $806.10
Hematology & Oncology $806.10
Dr. Geetha Naik, Md, MD
Hematology & Oncology — Payments: $13.86
Hematology & Oncology $13.86